Premier Perspectives The blog for insider insights in clinical development Medical and Regulatory Affairs How COVID-19 Is Making Operationalizing Gene Therapy Trials Even Tougher – And How We Handled It By Naomi Kautz January 14, 2021 Featured Posts Medical and Regulatory Affairs Site Selection, Manufacturing & Long-Term Follow-Up: Looming Challenges for a Rescue Phase 1/2 Gene Therapy Trial By Naomi Kautz January 12, 2021 Consulting How to Navigate Global Regulatory Frameworks & Expedited Programs for Gene Therapy Development in the U.S., EU, & Japan By Naomi Kautz December 21, 2020 1 × ALSO OF INTERESTKey Considerations When Designing a Phase 1...7 Questions About Clinical Evaluations for MDRNostalgia or Shell Shock? Assessing PTSD Is a...
